The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity (2022)
https://pubmed.ncbi.nlm.nih.gov/35040085/

Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients (2021)
https://pubmed.ncbi.nlm.nih.gov/34876490/

Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab (2021)
https://pubmed.ncbi.nlm.nih.gov/34905263/

Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk (2021)
https://pubmed.ncbi.nlm.nih.gov/34631754/

Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician (2021)
https://pubmed.ncbi.nlm.nih.gov/34622735/

MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients (2021)
https://pubmed.ncbi.nlm.nih.gov/34542870/

The “Climb” Towards Minimal Disease Activity in Psoriatic Arthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34302631/

Corticosteroid injection treatment for dactylitis in psoriatic arthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34471429/

A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action (2021)
https://pubmed.ncbi.nlm.nih.gov/33771760/

What influences patients’ opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study (2021)
https://pubmed.ncbi.nlm.nih.gov/33751029/

New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review (2021)
https://pubmed.ncbi.nlm.nih.gov/33710586/

Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study (2021)
https://pubmed.ncbi.nlm.nih.gov/33593933/

To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33547227/

Assessment of Widespread and Extraarticular Pain in Psoriatic Arthritis: A Case-control Study (2021)
https://pubmed.ncbi.nlm.nih.gov/33452167/

Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP study (2021)
https://pubmed.ncbi.nlm.nih.gov/33155160/

The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA-B27 Status? (2021)
https://pubmed.ncbi.nlm.nih.gov/32100954/

Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative (2020)
https://pubmed.ncbi.nlm.nih.gov/33542971/

ARS-CoV-2 IgM False- Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? (2020)
https://pubmed.ncbi.nlm.nih.gov/33298813/

Ixekizumab Improves Functioning and Health in the Treatment of Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results, COAST-X Trial (2020)
https://pubmed.ncbi.nlm.nih.gov/33044756/

Multimorbidity and comorbidity in psoriatic arthritis – a perspective (2020)
https://pubmed.ncbi.nlm.nih.gov/32940114/

Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment (2020)
https://pubmed.ncbi.nlm.nih.gov/32939675/

Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study (2020)
https://pubmed.ncbi.nlm.nih.gov/32804332/

Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices (2020)
https://pubmed.ncbi.nlm.nih.gov/32179713/

Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real- Life Study (2020)
https://pubmed.ncbi.nlm.nih.gov/32062827/

Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross-sectional, multi-country, observational study (2020)
https://pubmed.ncbi.nlm.nih.gov/32003056/

The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31847608/

Residual Disease Activity and Associated Factors in Psoriatic Arthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31676704/

Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries (2020)
https://pubmed.ncbi.nlm.nih.gov/31609525/

Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study (2019)
https://pubmed.ncbi.nlm.nih.gov/31920675/

Psoriatic Arthritis, Psoriatic Disease, or Psoriatic Syndrome? (2019)
https://pubmed.ncbi.nlm.nih.gov/31676545/

TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/31652079/

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients (2019)
https://pubmed.ncbi.nlm.nih.gov/31428989/

New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review (2019)
https://pubmed.ncbi.nlm.nih.gov/31410786/

Assessment of bone morphogenic protein 2 and interleukin-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study (2019)
https://pubmed.ncbi.nlm.nih.gov/31376251/

Occult axial involvement in patients with psoriatic arthritis mutilans: a case report (2019)
https://pubmed.ncbi.nlm.nih.gov/31309780/

The Assessment of Disease Activity in Psoriatic Arthritis: MDA, VLDA, DAPSA, or Something Else? (2019)
https://pubmed.ncbi.nlm.nih.gov/31262750/

Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting (2019)
https://pubmed.ncbi.nlm.nih.gov/30620284/

Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statement (2019)
https://pubmed.ncbi.nlm.nih.gov/30557127/

Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30554407/

Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries (2019)
https://pubmed.ncbi.nlm.nih.gov/30442648/

Role of comorbidities in spondyloarthritis including psoriatic arthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30338414/

What Should Be the Primary Target of “Treat to Target” in Psoriatic Arthritis? (2019)
https://pubmed.ncbi.nlm.nih.gov/30219765/

Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30183600/

Clinical implications of peripheral new bone formation in psoriatic arthritis: a literature-based review (2019)
https://pubmed.ncbi.nlm.nih.gov/30183592/

Abatacept for the treatment of psoriatic arthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/30246575/

Physician’s Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study (2018)
https://pubmed.ncbi.nlm.nih.gov/29907666/

Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study (2018)
https://pubmed.ncbi.nlm.nih.gov/29854850/

Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease (2018)
https://pubmed.ncbi.nlm.nih.gov/29516409/

The Sex Influence on Response to Tumor Necrosis Factor-α Inhibitors and Remission in Axial Spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29419448/

From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications (2018)
https://pubmed.ncbi.nlm.nih.gov/29338498/

Consensus on the management of patients with psoriatic arthritis in a dermatology setting (2018)
https://pubmed.ncbi.nlm.nih.gov/29220551/

The Sex Influence on Response to Tumor Necrosis Factor-α Inhibitors and Remission in Axial Spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29419448/

Minimal Disease Activity as a Treatment Target in Psoriatic Arthritis: A Review of the Literature (2018)
https://pubmed.ncbi.nlm.nih.gov/29142032/

Unmet Needs in Axial Spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/28779298/

Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology (2017)
https://pubmed.ncbi.nlm.nih.gov/29185959/

Psoriatic arthritis: is it time to treat-to-target or target to treat? (2017)
https://pubmed.ncbi.nlm.nih.gov/29067586/

Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts (2017)
https://pubmed.ncbi.nlm.nih.gov/28822731/

Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate (2017)
https://pubmed.ncbi.nlm.nih.gov/28589323/

Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort (2017)
https://pubmed.ncbi.nlm.nih.gov/28572467/

Mesenchimal stem cells: a possible role in the pathogenesis and treatment of spondyloarthritis (2017)
https://pubmed.ncbi.nlm.nih.gov/28535615/

The role of IL-17 in the treatment of psoriatic arthritis (2017)
https://pubmed.ncbi.nlm.nih.gov/28485176/

Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients (2017)
https://pubmed.ncbi.nlm.nih.gov/27782869/

Secukinumab for ankylosing spondylitis and psoriatic arthritis (2016)
https://pubmed.ncbi.nlm.nih.gov/27799780/